Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-28

Clinical Trial Update: Green Coffee Extract and Metabolic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating green coffee extract for metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Green Coffee Extract (Green coffee extract)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED